Skip to content

Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo

Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04912635
Enrollment
300
Registered
2021-06-03
Start date
2020-09-25
Completion date
2021-03-25
Last updated
2021-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Brief summary

This is a prospective, open-label study to evaluate the effectiveness of providing a dashboard with merged health metrics of CPAP (continuous positive airway pressure/ PAP) usage, self-reported sleepiness, blood pressure (BP) and activity (steps).

Interventions

OTHERNeo App

Neo is a smartphone-based dashboard application that utilizes concepts from behavioral science and health psychology to support patients to improve their adherence to therapy. This is done through behavior change techniques and intervention functions (Michie, Atkins & West, 2014). This app is designed to prompt participants' self-regulation of lifestyle and health behaviors, to support adherence to therapy. Such self-regulation of lifestyle behaviors is informed by presenting health metric data (through wearables, myAir (biofeedback) and self-report), in an easy to understand dashboard platform on the app. Participants will be asked to use their PAP device (as normal), use a Withings blood pressure cuff and activity monitor. This data is brought into the Neo app through an API Exchange gateway. This data will be presented to the participant and communicated in an easy to understand way.

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant is at least 18 years old. * Participant is using a ResMed AirSense 10 device and ResMed myAir mobile app. * Participant has been using CPAP therapy for less than 2 weeks. * Participant has been enrolled in myAir for less than 2 weeks. * Participants have self-reported resistant hypertension and they take 3 or more drugs to treat their hypertension. * Participant owns a mobile device compatible with the Neo app (Android Jelly Bean, v16, 4.1.x or newer, and iOS 8 or newer) * Participant is somewhat to fairly confident about being able to use Bluetooth connected devices and apps * Participant consents to download the Neo app, Withings app, create a Withings account, and sync Withings data to ResMed's Project Neo. * Willing and able to give informed consent * Can read and comprehend written and spoken English

Exclusion criteria

* Are participating in another app-based research study * Cannot participate for the full duration of the study (at least 45 days) * Unable to read or write English * Participant is pregnant * Participant is on Medicare

Design outcomes

Primary

MeasureTime frameDescription
Mean CPAP use hours6 weeksMean PAP use hours (mean hours per day) at 6 weeks following enrollment into the study compared to the control group.

Secondary

MeasureTime frameDescription
App Use6 weeksPercentage of participants that actively use the Neo app as determined by daily active users, weekly active users and time spent in the app.

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026